Dxcover Highlights Liquid Biopsy Platform Performance in Multiple Settings
Glasgow, UK, April 2, 2026 — Dxcover, a global leader in AI-enabled technologies, today announced the presentation of multiple studies at the Ameri…
Key Milestone Signals Readiness for Regulated Diagnostic Deployment
Glasgow, UK, March 3, 2026 — Dxcover, a global leader in AI-enabled technologies, today announced that its breakthrough liquid biopsy medical device has s…
GLASGOW, UK, February 13, 2026 — Dxcover, a global leader in innovative AI-enabled technologies, today announced the availability of its UKCA1-marked, blood-based brain cancer early detection test in the UK.
The new validated test has de…
Date: 04 August 2025 – GLASGOW, Scotland – Dxcover, a clinical-stage oncology diagnostics company developing and commercializing its Multiomic Spectral Analysis platform (MOSA-Dx), today announced the strategic expansion of its Scientific Advi…
Date: 24 June 2025
Opens U.S. headquarters in Nashville – a leading healthcare and life sciences hub
Building the foundation for clinical collaborations and commercialization
Nashville, TN – Dxcover, a UK-based company improving early …
GLASGOW, Scotland (April 30, 2025)
Dxcover Limited, a clinical-stage diagnostics company pioneering its multiomic spectral analysis (MOSA-Dx) for early detection of solid tumour cancers, today announced the presentation of real-world data show…
February 03, 2025 09:00 AM GMT
New capital raise from existing investors, as well as new investors, Macmillan Cancer Support and Maven Capital Partners, to drive innovation and commercial opportunities
GLASGOW, Scotland – Dxcover …
Luke Pike MD, DPhil, Radiation Oncologist, joins Dxcover Scientific Advisory Board to advise the company on brain cancer diagnostic early detection clinical applications
September 03, 2024 05:24 AM Eastern Daylight Time
GLASGOW,…
Distinguished Abstract Award to be presented Wednesday July 31 at Academy of Diagnostics & Laboratory Medicine Annual Meeting in Chicago.
GLASGOW, Scotland & NASHVILLE, Tenn.–(BUSINESS WIRE)–Dxcover Limited, …
We are thrilled to announce that Abigail Lishman has joined our team as the Head of Commercial Development in the UK and EU.
Abigail brings a wealth of experience from business development roles in diagnostics and devices, where she played a p…